National Vision EV/EBIT EYE

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2018.

Today, Oct 23, 2026: 19.2×
8-year median: 46.7×
Against its 8-year history: 10th; percentile: 0 is its lowest day, 100 its highest
8-year range: 14.7× to 448×
Peer median: 26.2×

National Vision's EV/EBIT is 19.2× as of Oct 23, 2026.

That is below its 8-year median of 46.7×, lower than on 90% of days in the last 8 years.

Over that time it ranged from 14.7× in Jan 2022 to 448× in Oct 2020.

The median for 10 medical instruments and supplies stocks of a similar size is 26.2×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	19.2×	17.2×	51.9×
2025	50.3×	43.2×	76.3×
2024	57.3×	53.5×	88.2×
2023	70.7×	27.5×	70.7×
2022	42.4×	14.7×	44.5×
2021	18.4×	17.8×	84.3×
2020	74.9×	22.1×	448×
2019	52.1×	43.5×	63.3×
2018	45.1×	41.9×	58.0×

Against its peers

Companies in Medical - Instruments & Supplies nearest National Vision's size, closest first, today.

Company	EV/EBIT
EYENational Vision	19.2×
CDRECadre	23.2×
BVSBioventus	26.2×
STAAStaar Surgical	57.7×
LMATLemaitre Vascular	22.6×
IRMDIradimed	37.7×
INSPInspire Medical Systems	32.6×
UFPTUFP Technologies	24.9×
ATRCAtriCure	208×
MOVMovado	11.8×
WRBYWarby Parker	n/m
Peer median	26.2×

Where National Vision ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on National Vision

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.